APRN: Diagnosing Diabetes with A1C
The ADA recently endorsed assessing the level of a patient's glycated hemoglobin A1C (A1C) as a method for diagnosing diabetes and discussed the value in estimated average glucose (eAG), hemoglobin variants, and the variability of lab testing versus point-of-care (POC) devices.
APRN should understand the meaning of the test values as well as the accuracy level of the tests to make appropriate decisions when interpreting A1C as a diagnostic tool and indicator of glycemic control. As successful glycemic control is achieved in only about one third of all patients. APRN are in a key position to use the approved testing to facilitate an increase in successful treatment, which would lead to a reduction in cost and health burden of both microvascular and macrovascular diabetes-related complications. This would reduce preventable complications, injury, and premature death while improving the health and quality of life for individuals.
Purpose/Goal: To provide the APRN with information about the diagnosis and management of diabetes and the use of glycemic markers.
1. Outline the recommendations from selected professional organizations for diagnosing and treating diabetes.
2. Discuss the interpretation of glycemic markers in glycemic control.
Alethea N. Hill PhDc, MSN, RN, ANP-BC; Susan J. Appel PhD, ACNP-BC, CCRN, FNP-BC
The planners and author(s) of this continuing nursing education activity have disclosed no relevant financial relationships with any commercial companies pertaining to this activity.
Contact Hours: 2.4
Expiration Date: 12/31/2014
Member Price: $40.00
Non-Member Price: $60.00